TMEM40 inhibitors refer to a class of chemical compounds that specifically target the Transmembrane Protein 40 (TMEM40), a protein encoded by the TMEM40 gene, which is part of a larger family of transmembrane proteins. TMEM40 is known to span the cellular membrane and plays a role in various cellular functions, particularly in the regulation of membrane dynamics, ion transport, and signaling processes. The structure of TMEM40 is characterized by multiple hydrophobic domains that anchor the protein to the lipid bilayer, making it an integral membrane protein. TMEM40 inhibitors, therefore, are designed to interact with these regions or with key domains that modulate the protein's activity within cellular processes such as signal transduction or ion channel regulation. The inhibition of TMEM40 can alter the physical and biochemical behavior of membranes, as well as downstream signaling pathways, offering insight into fundamental cellular biology.
Chemically, TMEM40 inhibitors are diverse, often consisting of small molecules with high specificity to the protein's active or regulatory sites. They may function by binding to hydrophobic pockets within the transmembrane domains or by disrupting protein-protein interactions that are critical for TMEM40's role in cellular signaling. The design of these inhibitors typically requires a deep understanding of TMEM40's structure through methods like X-ray crystallography or cryo-electron microscopy, which provide details on the binding sites and conformational states of the protein. In addition, TMEM40 inhibitors can reveal broader interactions of this protein with cellular organelles such as the endoplasmic reticulum and Golgi apparatus, thus allowing further exploration of its role in intracellular trafficking and protein folding. The study of these inhibitors also opens avenues for understanding how TMEM40 influences cellular homeostasis and signaling networks at the molecular level.
SEE ALSO...
Items 11 to 20 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and halts RNA synthesis, which could lead to reduced transcription of the TMEM40 gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol affects sirtuin activity and could potentially increase TMEM40 expression by epigenetic modifications that favor gene activation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates Nrf2, potentially increasing TMEM40 expression by inducing antioxidant response element-mediated gene transcription. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C forms DNA crosslinks, possibly leading to repression of gene expression including TMEM40. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3, potentially enhancing TMEM40 expression by modulating Wnt signaling and stabilizing transcription factors. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, potentially disrupting DNA replication and TMEM40 gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in protein synthesis; this could reduce TMEM40 synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially decreasing the transcription of TMEM40 mRNA. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts ER to Golgi transport, which might affect the processing and expression of transmembrane proteins like TMEM40. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMPK, which could lead to enhanced TMEM40 expression by influencing cellular energy balance and gene transcription. | ||||||